Ramji Srinivasan, a major player in the bio-tech industry, has made significant strides in the field of genetic screening. Currently, Srinivasan is the co-founder and CEO of Teiko.bio, a company that specializes in immune profiling from blood. He co-founded and served as CEO of Counsyl, a company dedicated to women's health genetic screening. This innovative platform tests for hundreds of mutations and genetic disorders in parents planning to have children, providing crucial information for prospective parents. Under Srinivasan's leadership, Counsyl tested over a million patients.

Not only did Srinivasan lead the Counsyl in its scientific endeavors, but he also successfully orchestrated Counsyl's acquisition by Myriad Genetics, Inc. This merger, which saw a transaction of $375M in cash and stock, further solidified Counsyl's position in the market and underscores Srinivasan's ability to navigate complex business transactions and lead companies towards growth and success.

Holding both a B.S. in Computer Science and an M.S. in Financial Mathematics from Stanford University, Srinivasan's academic background laid the foundation for his leadership in technological and medical advancements. His extensive experience, both academically and professionally, in the fields of technology, finance, and bio-tech, positions him as a knowledgeable and credible voice in these areas.

Biology Biotechnology, Technology, Science and Technology Professionals, CEO, Business Founders, Genetics, Health, Science, Mergers and Acquisitions, Finance,